Zoetis (ZTS) Q3 2026 Earnings Call: Guidance and Outlook
Zoetis updated its full year 2026 financial guidance, narrowing its revenue range and raising expectations for adjusted net income and diluted EPS.
About Zoetis. Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools.
Dombey's summary of the Zoetis Q3 2026 earnings call held Nov 5, 2026, written from the call itself. Every figure on this page was checked against what was said on the call, and quoted lines are management's own words; we do not add estimates or prices. The tone score is our read of management's wording, guidance and answers. Check figures against the company's SEC filings before acting. This is research, not investment advice.